干预瘤学的回顾性临床研究:相关性和挑战
Johannes Uhlig1,2, Thomas Kroencke3, Hyun S Kim4
1Department of Clinical and Interventional Radiology, University Medical Center Goettingen, Goettingen, Germany. johannes.uhlig@med.uni-goettingen.de.
Cardiovascular and interventional radiology
|August 7, 2025
概括
在干预瘤学 (IO) 中,回顾性临床研究对于分析现实数据至关重要,为治疗趋势和罕见疾病提供具有成本效益的见解. 这些研究补充了前性试验,解决了复杂的问题,并弥补了这个动态领域的证据缺口.
科学领域:
- 干预性瘤学干预性瘤学
- 临床研究方法论 临床研究方法论
背景情况:
- 追溯研究利用现有数据进行临床见解.
- 它们对研究具有成本效益和时间效率.
- 对于探索现实世界治疗趋势,长期影响和罕见疾病至关重要.
研究的目的:
- 突出回顾性研究在干预瘤学 (IO) 中的关键作用.
- 为了强调它们在产生假设和营销后监测方面的价值.
- 讨论如何最大限度地提高它们的效用和解决它们的局限性的策略.
主要方法:
- 对现有临床数据的分析.
- 应用先进的统计方法.
- 强调强大的数据质量,明确的目标和透明度.
主要成果:
- 追溯研究为现实世界IO实践提供了宝贵的见解.
- 它们有效地解决了在道德或后勤方面具有挑战性的研究问题.
- 这些研究补充了随机对照试验 (RCT) 和其他前性设计.
结论:
- 对于干预瘤学的证据生成,回顾性研究是不可或缺的.
- 确保方法严谨是克服诸如偏见和有限因果推断等挑战的关键.
- 它们与前性研究的整合弥合了这个快速发展的领域的关键知识差距.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
8.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


